Vecabrutinib | Interleukin Related interleukin-related.com

Product Name :
Vecabrutinib

Search keywords :
Vecabrutinib

drugId :
null

Target Vo:
Tyrosine-protein kinase BTK

Target Vo Short Name :
BTK

Moa_Name:
Tyrosine-protein kinase BTK inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sunesis Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Lymphoma, B-Cell, Marginal Zone

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PTEN Rabbit mAb Purity
FGFR1 Rabbit mAb Autophagy
Phospho-ULK1 (Ser556) Antibody: Phospho-ULK1 (Ser556) Antibody is an unconjugated, approximately 113 kDa (Calculated)/130 kDa (Observed), rabbit-derived, anti-ULK1 (Ser556) monoclonal antibody. Phospho-ULK1 (Ser556) Antibody can be used for: WB expriments in human, mouse background without labeling.

Author: Interleukin Related

Related Posts